Form 4 for HUM Humana
Accepted 2026-09-03 13:32:26 ET · period of report 2026-09-01 · accession 0002151421-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 13:32 | 2026-09-01 | HUM | Nundy Shantanu | Chief Medical Off | A - Grant | $0.00 | +2,549 | 2,549 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Humana Common | 2026-09-01 | A | A | 2,549 | $0.00 | 2,549 | D | — | — | (F1) Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan. |